Newly designed molecule disrupts the infection mechanism of SARS-CoV-2

A team of scientists led by the Department of Energy's Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

Related Keywords

Kevin Weiss ,Connor Cooper ,Qiu Zhang ,Hugh Oneill ,Emily Henderson ,Audrey Labbe ,Russell Davidson ,Stephanie Galanie ,Brian Sanders ,Gwyndalyn Phillips ,University Of Tennessee Health Science Center ,Office Of Science ,Brookhaven National Laboratory ,Nature Communications ,National Virtual Biotechnology Laboratory ,Environmental Research ,Stanford University School Of Medicine ,Lawrence Berkeley National Laboratory ,Technology Innovation Program ,Office Of Basic Energy Sciences ,Northeastern University ,Los Alamos National Laboratory ,University Of Chicago ,Department Of Energy Oak Ridge National Laboratory ,Argonne National Laboratory ,National Accelerator Laboratory ,Utah State University ,National Institutes Of Health Institute ,Oak Ridge National Laboratory ,Jerry Parks ,Molecular Biophysics ,Structural Molecular Biology ,Spallation Neutron Source ,Stanford Synchrotron Radiation Lightsource ,Accelerator Laboratory ,Tennessee Health Science Center ,Stanford University School ,Cells Industry Focus ,Hugho Neill ,Marti Head ,Basic Energy Sciences ,National Institutes ,National Institute ,General Medical ,Molecule ,Cars ,Ars Cov 2 ,Coronavirus ,Covid 19 ,Nzyme ,Immune Response ,Immune System ,Laboratory ,Mammalian Cells ,Protein ,Research ,Virus ,